By William Gullotti
Buffalo, N.Y., Aug. 23 – Citigroup Global Markets Holdings Inc. priced $700,000 of 0% market-linked securities – leveraged upside participation to a cap and contingent downside due Aug. 4, 2025 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The payout at maturity will be par plus 1.5 times any ETF gain, subject to a maximum return of par plus 75%.
If the ETF falls by up to 40%, the payout will be par. Otherwise, investors will be fully exposed to ETF decline.
The notes are guaranteed by Citigroup Inc.
Wells Fargo Securities LLC and Citigroup Global Markets Inc. are the agents.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Market-linked securities – leveraged upside participation to a cap and contingent downside
|
| Underlying fund: | SPDR S&P Biotech ETF
|
| Amount: | $700,000
|
| Maturity: | Aug. 4, 2025
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par plus 1.5 times any ETF gain capped at par plus 75%; if ETF falls by up to 40%, par; otherwise, full exposure to ETF decline from initial level
|
| Initial level: | $81.13
|
| Barrier level: | $48.678; 60% of initial level
|
| Pricing date: | July 29
|
| Settlement date: | Aug. 3
|
| Agents: | Wells Fargo Securities LLC and Citigroup Global Markets Inc.
|
| Fees: | 2.075%
|
| Cusip: | 17330PJQ3
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
